sgt-003
sgt-003: developed by 1 company · 1 FDA decision. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Solid Biosciences Inc. (SLDB) | Phase 3 |
FDA Decisions
FDA_MeetingCompany plans to request FDA meeting in mid-2025 to discuss potential accelerated approval regulatory pathway for SGT-003(SLDB)
Frequently asked questions
Who is developing sgt-003?
sgt-003 is being developed by Solid Biosciences Inc..
What is sgt-003's latest FDA decision?
The most recent tracked FDA decision for sgt-003 is FDA_Meeting for Company plans to request FDA meeting in mid-2025 to discuss potential accelerated approval regulatory pathway for SGT-003.
Get deeper analysis on sgt-003
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis